Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank50
3Y CAGR-25.6%
5Y CAGR-4.6%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-25.6%/yr
Annual compound
5Y CAGR
-4.6%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.05 | -17.1% |
| 2024 | 0.06 | -34.2% |
| 2023 | 0.10 | -24.5% |
| 2022 | 0.13 | +39.8% |
| 2021 | 0.09 | +36.9% |
| 2020 | 0.07 | +101.5% |
| 2019 | 0.03 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |